CANCER

Several biotech companies are utilizing their proprietary technology platforms for developing new cancer treatments.

Examples include BioInvent, Genmab, Pharmexa, Symphogen (antibodies), Santaris Pharma (RNA analogues), Nordic Vaccine, Meabco (metal ions, small molecules developed against new targets), Active Biotech, Topotarget (small molecules against new targets), SpectraCure (photodynamic dosing), Dako (diagnostics), DanDrit (dendritic cells) and Zgene (gene diagnostics).